Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by identifying an existing drug with the potential to prevent deadly heart ...

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

Mouth taping may help reduce mouth breathing during sleep. Learn this practice's possible benefits and risks and what the ...

PhD student Ahmed Ramadan emerged with first prize and the people’s choice award for his engaging explainer about a ...

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...

About 10% of Americans say they have chronic insomnia, and millions of others report poor sleep quality. Ongoing research has ...

A north Derbyshire woman is raising money for a cause close to her heart in her new role with a charity dedicated to ...

Research has found that bad sleep could lead to numerous health problems, including heart disease. Here are recommendations to improve sleep.